Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001093557-18-000135
Filing Date
2018-06-26
Accepted
2018-06-26 20:12:53
Documents
1
Period of Report
2018-06-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4/A  
1 PRIMARY DOCUMENT edgardoc.xml 4/A 3547
  Complete submission text file 0001093557-18-000135.txt   4899
Mailing Address 6340 SEQUENCE DRIVE SAN DIEGO CA 92121
Business Address 6340 SEQUENCE DRIVE SAN DIEGO CA 92121 8582000200
DEXCOM INC (Issuer) CIK: 0001093557 (see all company filings)

EIN.: 330857544 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address AMYLIN PHARMACEUTICALS INC 9360 TOWNE CENTRE DR SAN DIEGO CA 92121
Business Address
FOLETTA MARK G (Reporting) CIK: 0001236389 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-51222 | Film No.: 18920347